Status:
COMPLETED
Follicle Stimulating Hormone (FSH) Receptor Polymorphisms in In-Vitro Fertilization Cycles.
Lead Sponsor:
University Reproductive Associates
Collaborating Sponsors:
Ferring Pharmaceuticals
Conditions:
Infertility
Eligibility:
FEMALE
18-35 years
Brief Summary
This study is being done to identify if certain sequences (patterns) of key genes (called polymorphisms) may predict a response to fertility medications. The investigators will also determine if the i...
Detailed Description
All IVF patients who meet inclusion criteria and not exclusion criteria will be asked to participate in this study. Upon consent, a blood sample will be obtained in 2 EDTA containing lavender topped t...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 100 women less than 35 years old at time of signing the Informed Consent Form.
- Day 3 FSH level less than or equal to 10 mIU/ml with an estradiol \< 70 pg/ml
- Day 3 antral follicle count of greater than 10 follicles total.
- Couples who have male factor infertility, tubal factor infertility, and unexplained infertility.
- Exclusion Criteria patients who have:
- Endometriosis
- Polycystic ovarian syndrome
Exclusion
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT01002885
Start Date
July 1 2009
End Date
May 1 2013
Last Update
December 10 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Reproductive Associates
Hasbrouck Heights, New Jersey, United States, 07604
2
University Reproductive Associates
Hoboken, New Jersey, United States, 07030